TSE:4527Personal Products
Is Rohto (TSE:4527) Using Digital Amblyopia Therapy To Quietly Redefine Its Eye-Care Moat?
Luminopia, Inc. recently announced an exclusive licensing agreement granting Rohto Pharmaceutical Co., Ltd. rights to develop and commercialize its digital therapy for pediatric amblyopia in Japan, with Rohto leading local clinical and regulatory efforts.
This collaboration gives Rohto a new entry point into prescription-grade digital health therapies, broadening its traditional eye-care portfolio into software-based treatments.
Next, we will examine how this move into digital pediatric eye...